Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2006
12/13/2006EP1730116A1 4-carbox pyrazole derivates useful as anti-viral agents
12/13/2006EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
12/13/2006EP1729774A1 Pyrrolidine compounds
12/13/2006EP1729723A1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers
12/13/2006CN1878771A Substituted bicyclic quinazolin-4-ylamine derivatives
12/13/2006CN1878761A Arylindenopyridines and arylindenopyridines and their use as adenosine A2a receptor antagonist
12/13/2006CN1878759A Pyridazin-3 (2H) -one derivatives and their use as PDE4 inhibitors
12/13/2006CN1878552A Methods of use of thrombin receptor antagonists
12/13/2006CN1878547A Synthesis of oligomeric epicatechin and catechin-derived procyanidins
12/13/2006CN1876651A 2,2'-diamino-4,4'- bithiazole transitional metal chelate and its supermolecular magnetic material and its preparation method
12/13/2006CN1289509C Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, and pharmaceutical compositions containing same
12/13/2006CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
12/13/2006CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/12/2006US7148359 Protease inhibitors; viricides; purity, crystal structure
12/12/2006US7148357 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
12/12/2006US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006US7148246 Therapy, prevention diseases of fatty acid metabolism, glucose utilization; insulin resistance; antidiabetic agents; antilipemic agents
12/12/2006US7148242 N-formyl hydroxylamine compounds, compositions and methods of use
12/12/2006US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006US7148224 Pyrazinone derivatives
12/12/2006US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006US7148219 Biaryl heterocyclic compounds and methods of making and using the same
12/12/2006US7148217 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
12/12/2006US7148029 Generating antibodies; quantitative analysis
12/12/2006CA2281695C Process for the preparation of substituted thiazolidinedione
12/12/2006CA2121871C A prophylactic or therapeutic drug for renal diseases
12/07/2006WO2006130493A2 Heterocycles useful as modulators of ion channels
12/07/2006WO2006129842A1 Novel aminopyridine derivative having selective aurora-a inhibitory activity
12/07/2006WO2006129788A1 Agent for regeneration and/or protection of nerves
12/07/2006WO2006129609A1 2-naphthylimino-5,5-disubstituted-1,3-thiazin derivative
12/07/2006WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006WO2006129583A1 Pyrazolone derivative
12/07/2006WO2006129432A1 Carboxamide compound and use thereof
12/07/2006WO2006129100A1 Novel compounds
12/07/2006WO2006128909A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/07/2006WO2006128692A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006WO2006128688A1 Process for the preparation of pramipexole
12/07/2006WO2006100081A3 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/07/2006WO2006057977A3 Cycloalkyl piperidine tachykinin receptor antagonists
12/07/2006WO2005112919A8 Self-immolative linkers and drug conjugates
12/07/2006WO2005112919A2 Self-immolative linkers and drug conjugates
12/07/2006US20060276645 Novel carboxylic acid derivatives, their preparation and use
12/07/2006US20060276641 Heating reaction mixture containing 11-chlorodibenzo[b,f][1,4]thiazepine and 1-(2-hydroxyethoxy)ethyl piperazine, potassium bicarbonate, and potassium iodide in solvent; thin layer chromatography
12/07/2006US20060276640 Process for making aztreonam
12/07/2006US20060276522 Benzisothiazol-3-one-carboxylic acid amides as phospholipase inhibitors
12/07/2006US20060276521 e.g. N-{4-[2-(4-{[amino(imino)methyl]amino}phenyl)ethyl]-1,3-thiazol-2-yl}acet-amide; vascular adhesion protein (semicarbazide sensitive amine oxidase) inhibitor; antidiabetic, hypotensive agent; non-insulin dependent diabetis obesity, retinopathy complications, atherosclerosis, macular edema
12/07/2006US20060276520 Rhodanine derivatives and pharmaceutical compositions containing them
12/07/2006US20060276517 Non-systemic control of parasites
12/07/2006US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006US20060276514 Tyrosine kinase inhibitors
12/07/2006US20060276509 Tripeptidyl peptidase inhibitors
12/07/2006US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006US20060276474 Novel carboxylic acid derivatives, their preparation and use
12/07/2006US20060276461 Prostaglandin analogs
12/07/2006US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
12/07/2006US20060276434 3-Carbonylaminothiophenes and their use as fungicides
12/07/2006US20060276433 Hydrazone derivative
12/07/2006US20060276413 New effector conjugates, methods for their preparation and their pharmaceutical use
12/07/2006CA2610695A1 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006CA2610692A1 Ep2 agonists which may have an ep3 agonistic effect for regeneration and/or protection of nerves
12/07/2006CA2609355A1 Organic compounds
12/06/2006EP1728790A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/06/2006EP1727821A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
12/06/2006EP1727816A1 Silylated carboxamides
12/06/2006EP1727815A1 Ether derivatives, their manufacture and use as pharmaceutical agents
12/06/2006EP1727809A1 Substituted morpholine and thiomorpholine derivatives
12/06/2006EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006EP1727797A1 Process for cross coupling indoles
12/06/2006EP1572668A4 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
12/06/2006EP1438304B1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/06/2006EP1291343B1 Hydroxyformamidine derivatives and medicines containing the same
12/06/2006CN1875018A Process for preparing thiazolidinediones
12/06/2006CN1874770A Therapeutic agent for keratoconjunctiva disorder
12/06/2006CN1874768A N3 alkylated benzimidazole derivatives as MEK inhibitors
12/06/2006CN1288153C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
12/05/2006US7145018 Novel desepoxydidehydroepothilone, useful for treating taxol-resistant cancer
12/05/2006US7145017 Preparation of Aztreonam
12/05/2006US7145006 PNA monomer and precursor
12/05/2006US7144911 Anti-inflammatory medicaments
12/05/2006US7144910 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease
12/05/2006US7144906 Heterocyclic compounds
12/05/2006US7144904 desferrithiocin analogs used as siderophores, for treatment of malaria in humans
12/05/2006US7144903 CCR4 antagonists
12/05/2006US7144899 Thrombin inhibitors
12/05/2006US7144898 Indole derivatives for the treatment of depression and anxiety
12/05/2006US7144896 heterocyclic imines such as 3-[6-(1-Methanesulfonyl-1-methyl-ethyl)-quinolin-8-yl]-N-[6-(4-methylsulfanyl-phenyl)-pyridin-3-yl]-benzamide, used as phosphodiesterases (pde4) inhibitors; side effect reduction
12/05/2006US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006US7144886 Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents
12/05/2006CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
11/2006
11/30/2006WO2006127396A1 Par2-modulating compounds and their use
11/30/2006WO2006126695A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006WO2006126681A1 Pharmaceutical composition
11/30/2006WO2006126171A2 New antibiotic derivatives
11/30/2006WO2006126074A2 Heterocyclic derivatives
11/30/2006WO2006125972A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006WO2006125807A1 Thiazole derivatives and use thereof